American Capital Advisory’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5K Buy
106
+2
+2% +$231 ﹤0.01% 338
2026
Q1
$12.4K Hold
104
0.01% 330
2025
Q4
$14.2K Buy
104
+1
+1% +$144 0.01% 308
2025
Q3
$15.2K Hold
103
0.01% 285
2025
Q2
$13.3K Buy
103
+1
+1% +$121 0.01% 283
2025
Q1
$12.2K Buy
102
+2
+2% +$248 0.01% 289
2024
Q4
$11.6K Hold
100
0.01% 288
2024
Q3
$13.5K Hold
100
0.01% 271
2024
Q2
$11.4K Hold
100
0.01% 249
2024
Q1
$10.5K Hold
100
0.01% 246
2023
Q4
$11.4K Buy
+100
New +$9.98K 0.01% 249

Other funds holding XYL

American Capital Advisory's XYL Position: Q2 2026 in Review

American Capital Advisory increased its Xylem (XYL) stake by 1.9% in Q2 2026, buying an estimated $231 and bringing the position to 106 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #338.

American Capital Advisory first reported a position in XYL in Q4 2023 and has held it in 11 quarters since. The position peaked at $15.2K in Q3 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • American Capital Advisory held 106 shares of Xylem worth $12.5K as of Q2 2026.
  • American Capital Advisory bought 2 Xylem shares in Q2 2026, an estimated $231.
  • Xylem made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #338 holding.
  • American Capital Advisory first reported a position in Xylem in Q4 2023 and has held it in 11 quarters since.
  • American Capital Advisory's Xylem position peaked at $15.2K in Q3 2025.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.